2021
DOI: 10.3390/nano11051075
|View full text |Cite
|
Sign up to set email alerts
|

Nanobiosystems for Antimicrobial Drug-Resistant Infections

Abstract: The worldwide increased bacterial resistance toward antimicrobial therapeutics has led investigators to search for new therapeutic options. Some of the options currently exploited to treat drug-resistant infections include drug-associated nanosystems. Additionally, the use of bacteriophages alone or in combination with drugs has been recently revisited; some studies utilizing nanosystems for bacteriophage delivery have been already reported. In this review article, we focus on nine pathogens that are the leadi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 221 publications
0
12
0
Order By: Relevance
“…Liposomes are nanosystems showing many advantages for antimicrobial drug-resistant infections, as recently reviewed [21]. MOX-loaded liposomes were recently demonstrated to have enhanced antitubercular activity in comparison with free drugs [22].…”
Section: Introductionmentioning
confidence: 99%
“…Liposomes are nanosystems showing many advantages for antimicrobial drug-resistant infections, as recently reviewed [21]. MOX-loaded liposomes were recently demonstrated to have enhanced antitubercular activity in comparison with free drugs [22].…”
Section: Introductionmentioning
confidence: 99%
“…There are no laboratory tests that can diagnose /exclude tetanus. 19,20 Wound culture rarely yields Clostridium tetani and are not available quick enough to aid diagnosis. Hence, the presentation of tetanus is so characteristic that a presumptive diagnosis should be made if a person is presenting with above mentioned symptoms.…”
Section: Discussionmentioning
confidence: 99%
“…DQ has previously been described as a drug that exhibits cross-resistance. Nanocarriers are among the options that have been explored in recent years to combat drug resistance [ 68 ].…”
Section: Pharmacological Usementioning
confidence: 99%
“…DQ, for example, has already been described as a drug that exhibits cross-resistance, i.e., the ability of coccidia to survive the anticoccidial effects of a drug to which they have never been exposed because they have already developed resistance to a chemical agent [ 73 ]. Options that have been explored in recent years to combat drug resistance include nanosystems [ 68 ].…”
Section: Pharmacological Usementioning
confidence: 99%